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IgM is expressed on the surface ofB lymphocytes but not on the surface ofIgM-
secreting plasma cells . This shift from the expression of surface IgM to that of the
secreted form is partly achieved by control at the level ofRNA processing . However,
post-translational regulation also plays a critical role . Thus, even when the mem-
brane form of IgM is synthesized in plasmacytoma cells, it fails to reach the cell
surface ; rather, it is retained within the endoplasmic reticulum (1, 2) . The molecular
basis of this differential handling of surface IgM in B cells and plasma cells is not
understood, although a B cell-specific protein that associates with membrane IgM
has been proposed to play a role (3) . Here, we present experiments that suggest that
the proteins that potentiate the surface expression ofmembraneIgM inB cells recog-
nize the COOH-terminal end of p.m chains and work through interaction with the
transmembrane segment .
All plasmids directing h expression contain the h transcription unit cloned between the
Eco RI and Xho I sites of a pSV2gpt derivative that includes an Xho I linker in the Barn
HI site. Plasmid pV-ltm directs the synthesis of um (but not l~,) chains under the control of
the V promoter/IgH enhancer, and is identical to pSVVjAm (plasmid No. 463) described
previously (1) . Plasmid pOG-pm (No. 773) directs p.m synthesis under the control ofthe (3-glo-
bin promoter and was constructed by transferring the Bgl II fragment of No. 463 (which
extends from C 1 through the rest of C,, into gpt) into a Bgl II-digested PSVpOGVA[Inll
vector (4) . Plasmids Nos. 938 and 940, which direct the expression of Am '1 and hm.2 mu-
tant H chains, were constructed by site-directed mutagenesis and are identical to pflG-14m ,
except for the changes in the gm transmembrane (Fig . 4) . For plasmid p(3G-R/H2 (No. 860),
a Pst I-Bgl I fragment that spans exons 5-8 of the mouse H-2Kb gene (5), was inserted be-
tween the Bcl I and Xho I sites of p#G-IL. . The X L chain transcription unit consists of an
Mlu I-BamHI fragment (gift of S . Emtage, Celltech, Slough, U.K .) in which the cytomega-
lovirus(HCMV) promoter and SV40 polyA site potentiate expression ofa mouse X1 cDNA .
Derivatives of pV -IA., p(3G-p .m , and pOG-p,/H2, which direct expression of both H and X
chains (Nos . 784, 785, and 903, respectively), were created by inserting the X1 transcription
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unit into the unique Eco RI site of the parental plasmid. An expression vector for human
CD8 (plasmid No. 782) was constructed by linking a CD8 cDNA Eco RI fragment (6) to
the HCMV promoter and cloning into pSV2neo with the vector providing the poly A site
(Fig. 1). The hybrid CD8/C/,4-C/,M gene (CD8/u4m; plasmid No. 808) was constructed by
cuttingtheCD8 cDNA fragment at theEcoRV sitejust preceding its transmembrane region
(6)andfusing to the ApaLI-XhoI C,,4-CMfragment ofplasmid No. 463, in which the Apa
LI site had been blunted by use of T4 polymerase and dGTP + dTTP The reading frame
across the fusion junction was verified by sequencing; the gene was linked to the HCMV
promoter and cloned into pSV2gpt.
Plasmacytoma J558L secretes X1 L chains. An Ig- derivative of mouse B cell lymphoma
M12(7)wasobtained from B. Chain (University College, London). Transfection oflymphoid
cell lines andCOS-7 cellswascarried out as previously described (4, 8). The M12 andCOS-7
cells were transfected with plasmids that included both the 1A and Xchain transcription units,
whereas pSV2gpt derivatives containing only the u chain unit were used forJ558L. COS-7
cells were trypsinized 24 h after transfection and distributed onto microscope slides; im-
munofluorescence wasperformed 24 h laterusingaconfocal microscope (1)on surface-stained
cells or afterfixation for 10 min in 4% paraformaldehyde in PBS and permeabilization with
NP-40. Analysis in theFAGS with FITC-conjugated anti-,u or anti-CD8 (OKT8; Ortho Di-
agnostic Systems Inc., Westwood, MA) reagents was performed on surface-labeled cells or
on cellslabeled after fixation for 5 min in 3.8% formaldehyde in PBS and permeabilization
for 3 min in 0.05% NP-40 in PBS.
Results
We have previously shown that transfectants oftheJ558L plasmacytoma that make
,um and X chains retain the membrane IgM in the endoplasmic reticulum (1). How-
ever, surface IgM expression is achieved in transfectants of the B cell lymphoma
M12 harboring a plasmid directing the synthesis of membrane IgM (Figs. 1 and
FIGURE 1.
￿
Structure of plas-
mids. The transcription units
are shown without vector se
PVH - ltm
￿
pHCMV-CD8
￿
quences. Ig sequences are in
14b
￿
Gg
￿
solid lines; H-2K6, SV40, and
t V
￿
12 34 M
￿
CD8
￿
CD8 sequences are hatched,
01 u u
￿
andthehumanS-globin andcy-
PVH
￿
Mi'~M2
￿
pHCMV
￿
tomegaloviruspromotersV')are
a
￿
a
￿
~_'A
￿
in open boxes. The IgH en-
An
￿
n
￿
M
￿
(H/R) R
￿
hancer is depicted
￿
and re- k-)
t Kb
￿
Bam HI; Bc, Bcl I; Bg, Bgl I;
p0G-ltm
￿
1 Kb
￿
pHCMV-CD8/g4m CD8
￿
M
~i
￿
M, Mlu I; P, Pst I; R, Eco RI;
'-'
￿
R, -g-
￿
X, Xho I. H/R and E/Ap de-
V4 4
2 g3 N -g"-
￿
r--- note the junction of Hind III r-r
￿
r" r"
￿
r"
￿
pHCMV ppG
￿
and Eco RI or EcoRV andApa
(H/R)
￿
13c
￿
x
￿
LI sites, respectively. The Bcl I
R
￿
BC
￿
deletion that takes out the As (E/Ap)
ppG-Ft/H2
￿
tailpiece (tp) and poly A site
pHCMV-X
￿
(An) in all h plasmids is
Vg gz g' g
￿
LV2, Ca
￿
depicted below pV-(.Lm. All w r:3§'WR M =
￿
0
￿
and CD8//tA plasmids encode t
￿
rm
pHCMV
￿
only themembrane form ofthe
H-2Kb
￿
nn
￿
e
￿
H chain; analysis by Northern
BC/P
￿
eg/x
￿
blot and SDS/PAGE revealed
that they encode mRNAs and
polypeptides oftheexpected sizes
(1, 4, and unpublished data).
POG
ec
￿
ec
￿
striction sites are abbreviated B, Deletion2 A). Does this distinction between B cell lymphoma and plasmacytoma reflect a
feature specific to plasma cells that inhibits surface expression ofIgM, or is it that
B cells contain an activity that facilitates transport of IgM to the cell surface? To
analyze this, we transfect6d a plasmid directing the synthesis ofA. and A chains
into the monkey fibroblast line COS-7. Immunofluorescence analysis (Fig. 3A) re-
vealed that IgM was made within the cell but was not transported to the surface.
This suggests that B cells contain factor(s) that facilitate the transport ofmembrane
IgM to the cell surface; in their absence, membrane IgM would be retained within
the cell.
The COOH-terminal Portion ofFpm Is Sufficient to Confer B CellSpecificity ofSurface Ex-
pression. In contrast to the membrane form, the secretory form of IgM proceeds
throughthe Golgi ofplasmacytoma and outofthe cell. Wetherefore suspected that
theintracellularretentionofmembrane IgMmightbemediated throughtheCOOH-
terminal end of tc. chains, as this is where IA. and us differ. To test this, we con-
structed a hybrid gene between CAand the human cell surface antigen CD8 (which
has a single extracellular domain and is a member of the Ig superfamily). The
CD8/A4m hybrid gene (Fig. 1) has the single extracellular CD8 domain linked to
the p C4, transmembrane, and cytoplasmic portions, and encodes a glycoprotein
of the predicted molecular weight (not shown). When the CD8/A4m chimeric pro-
tein is made in M12 cells, it is transported to the cell surface; in COS-7 cells, how-
ever, it is retained within the cell (Figs. 2 B and 3 B). This contrastswith CD8 itself,
which istransported to the surface in both cell types(Fig. 3 B, and datanot shown).
Thus, provision ofthe j. C4, transmembrane, and cytoplasmic portions is sufficient
to confer on CD8 the B cell-specific transportphenotypeofmembrane IgM. These
resultsnot only indicate that the sequence responsible forthe intracellularretention
of membrane IgM in non-13 cells is located at the COOH-terminal end of IA., but
also that this part of u. is sufficient for recognition by those factors that facilitate
surface IgM expression in B cells.
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g.,*1) or pSV2gpt(p#G-Iem*2) were stained with FITC-conjugated anti-IA.
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FIGURE 3 .
￿
Immunofluorescence analysis of(A)
COS-7 cells transfected witheitherpSV2gpt(p/3G-
A, + pHCMVX) or with pSV2gpt(pgG-p/-
H2 + pHCMVX) ; (B) COS-7 cells transfected
with either pSV2gpt(pHCMVCD8/p.4m) or with
pSV2neo(pHCMVCD8) .
Mutating the Transmembrane Segment Permits SurfaceIgMExpression in Non-BCells.
￿
The
results with the CD8/A4m protein suggest that alteration ofthe COOH-terminal end
of Am might overcome the retention of membrane IgM by non-B cells . We there-
fore constructed aplasmid that directs thesynthesis of ahybridHchain that iscom-
posed of V , Cw1, C#2, Cf ,3, and CIA domains linked to the transmembrane and
cytoplasmic segments of theMHC class I molecule H-2Kb (Fig . 1) ; MHC class I
molecules are expressed on the surface ofa wide variety of cells . The hybrid g/H2
molecules associated with XL chains and were efficiently transported to the surface
ofJ558L and M12 cells (Fig. 2 C); they were also transported to the surface ofCOS-
7 cells (Fig . 3 A) .
The fact that the IgM comprising the p/H2 H chains reached the cell surface
must be due to the change either in the transmembrane segment or in the cyto-
plasmic tail . We felt that, given the short length of the hm cytoplasmic tail, the al-
teration ofthe transmembrane segment was the more likely cause . Inspection of the
sequence of the segment ofhm chains that spans the membrane (Fig. 4) reveals that
while it containsno charged residues, it comprisestworegions(TTASTandYSTTVT)
that include polar amino acids . We therefore tested whether the mutant H chain
p.,n*1 (Fig . 4), in which these two regions of the l~ transmembrane segment have
been mutated so as to increase its hydrophobicity, would be transported to the cell
surface . This was indeed the case (Fig. 2 D) . In fact, mutation ofjust the NH2-
terminal portion of the transmembrane segment (mutant /Am*2) was sufficient to
allow surface IgM expression in plasmacytoma (Fig . 2 D) .Am*2
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EXTRACELLULAR TRANSMEMBRANE CYTOPLASMIC
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Transmembrane sequences. An asterisk denotes a translation stop.
Discussion
Membrane IgM is only able to proceed onto the cell surface in B lymphocytes.
In contrast, it is retained within the endoplasmic reticulum in plasmacytoma and
nonlymphoid cells. However, mutation of the transmembrane segment overcomes
this retention. This raises several questions. What retains membrane IgM within
the endoplasmic reticulum of non-B cells? How does mutating the transmembrane
segment overcome the retention? How is theretention obviated in surface IgM-ex-
pressing B lymphocytes?
Ourdemonstration that specific amino acid substitutions in the transmembrane
segment overcome the retention of membrane IgM in non-B cells means that this
retention must be mediated by interactions involvingthe transmembrane segment.
What proteins could mediate the retention? The H chain binding protein (BiP),
which is implicated in the intracellularretention of secretory IgM by B cells, is un-
likely to play a role, as no association between BiP and membrane IgM is found
in /,tm transfectants of the J558L plasmacytoma (9). Rather, if a protein of the en-
doplasmicreticulum is involved, it is likely to be aresident transmembrane protein.
However, the most striking feature of the mutant IA. chains is that they are more
hydrophobic than the wild type. Therefore, it may simply be that the transmem-
brane segment is toohydrophilic forstable incorporation into thelipidbilayer; mem-
brane incorporation might require a protein sheath.
How then do B cells overcome the intracellular retentionofmembrane IgM? Hom-
bach et al. (3) have described the isolation of a variant of theJ558L plasmacytoma
that transports IgM to the cell surface, and have shown that this variant now ex-
pressesan IgM-associated protein (B34) that is absent from theparentalJ558L. The
authors suggest that B34 is the product of the mb-1 gene isolated by Sakaguchi et
al. (10), and propose that B34 mediates the transport of membrane IgM to the cell
surface. From the data we present here, it is evident that the factor(s) that mediate
the transport of membrane IgM to the B cell surface need no more than the h C4,
transmembrane, and cytoplasmic portions for recognition. They must act by either
forming a sheath that allows stable incorporation of the g transmembrane segment
into the lipid bilayer, or they must displace an interaction that involves the trans-
membrane segment and that would otherwise cause retention.952
￿
WILLIAMS ET AL .
￿
BRIEF DEFINITIVE REPORT
Summary
Membrane IgM is expressed on the surface ofB lymphocytes . It is not transported
to the surface oftransfected plasmacytoma orCOS cells . Here, we show that muta-
tion of four hydrophilic amino acids in the p,m transmembrane is sufficient to over-
come the intracellular retention of membrane IgM in non-B cells . This suggests
that the B cell-specific IgM-associated proteins that have been postulated to assist
the transport ofmembrane IgM to the cell surface (3) act either by forming a hydro-
phobic sheath that surrounds the um transmembrane segment or by displacing an
interaction with this segment that would otherwise cause retention . Experiments
with a CD8/Ft hybrid H chain indicate that the proteins that assist the transport
of membrane IgM to the B cell surface at most need the h C4 and transmem-
brane/cytoplasmic portion for interaction .
We thank Roberto Sitia and Cesar Milstein for helpful discussions . A . R . Venkitaraman ac-
knowledges the support of New Hall, Cambridge .
Receivedfor publication 31 October 1989.
References
1 . Sitia, R ., M . S . Neuberger, and C . Milstein . 1987 . Regulation of membrane IgM ex-
pression in secretory B cells: translational and post-translational events . EMBO (Eur. Mol.
Biol. Organ.)J . 6:3969 .
2 . Hombach, J ., F. Sablitzky, K . Rajewsky, andM . Reth . 1988 . Transfected plasmacytoma
cells do not transport the membrane form ofIgM to the cell surface.J. Exp. Med. 167 :652 .
3 . Hombach, J ., L. Leclercq, A . Radbruch, K . Rajewsky, andM . Reth . 1988 . A novel 34-
kd protein co-isolated with the IgM molecule in surface IgM-expressing cells . EMBO
(Eur . Mol. Biol. Organ.)f . 7:3451 .
4 . Neuberger, M . S., andG . T. Williams . 1988 . The intron requirement for immunoglob-
ulin gene expression is dependent upon the promoter. Nucleic Acids Res. 16:6713 .
5 . Weiss, E ., L . Golden, R . Zakut, A . Mellor, K . Fahrner, S . Kvist, andR . A . Flavell . 1983 .
The DNA sequence of the H-2K 6 gene : evidence for gene conversion as a mechanism
for the generation of polymorphism in histocompatibility antigens. EMBO (Eur . Mol .
Biol. Organ.)j 2:453 .
6 . Littman, D . R ., Y. Thomas, P . J . Maddon, L . Chess, and R . Axel . 1985 . The isolation
and sequence of the gene encoding T8 : a molecule defining functional classes ofT lym-
phocytes . Cell. 40:237 .
7 . Kim, K . J ., C . Kanellopoulos-Langevin, R . W. Merwin, D. H . Sachs, and R . Asofsky.
1979 . Establishment and characterization ofBALB/clymphoma lines with B cell proper-
ties. f . Immunol. 122:549 .
8 . Mason, J .O ., G. T Williams, andM . S . Neuberger. 1985 . TYanscription cell type specificity
is conferred by an immuglobulinV  gene promoter that includes a functional consensus
sequence . Cell . 41:479 .
9 . Sitia, R ., M . Neuberger, C . Alberini, P Bet, A . Fra, C . Valetti, G . Williams, and C .
Milstein. 1989 . Developmental regulation ofIgM secretion : the role of the carboxyter-
minal cysteine . Cell. In press .
10 . Sakaguchi, N ., S . Kashiwamura, M . Kimoto, P. Thalmann, and F . Melchers . 1988 . B
lymphocyte lineage-restricted expression of mb-1, a gene with CD3-like structural prop-
erties . EMBO (Eur . Mol. Biol. Organ.) j 7 :3457 .